Paul R. Edick - Oct 5, 2021 Form 3 Insider Report for Xeris Biopharma Holdings, Inc. (XERS)

Role: Title: Chairman and Chief Executive Officer Exhibit 24 - Power of Attorney, Director
Signature: /s/ Beth Hecht as Attorney-in-Fact
Stock symbol: XERS
Transactions as of: Oct 5, 2021
Transactions value $: $0
Form type: 3
Date filed: 10/5/2021, 05:23 PM
Next filing: Nov 12, 2021

No securities are beneficially owned.

Remarks:

Title: Chairman and Chief Executive Officer Exhibit 24 - Power of Attorney